API
CDMO
About us
Services

Olpha - CDMO/CMO

Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines and chemical pharmaceutical products

Olpha Group includes a network of medical and pharmaceutical enterprises specialising in their own discipline, covering a wide range of areas.

Key areas
The key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. Olainfarm has a long-standing technological and know-how advantage in adamantane, quinuclidine and nitrofurane chemistry.

Certifications
Olpha is certified in accordance with the requirements of the EU GMP for APIs and FDFs, the U.S. cGMP for certain APIs (FDA), TGA for FDFs (Australia), CEP for certain APIs, ISO 14001 Environmental Management System and ISO 17025 Laboratory...

Read full company description
Address: 5 Rupnicu Street, LV-2114, Olaine
Latvia
Latvia Local time:

EU-GMP for APIs and CEP for certain APIs

Exporting to over 50 countries worldwide

Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry

Our services:

Drug Substance
Drug Product

Production scale:

medium

Response time:

label.follow_us Follow us:
Employees:
1,000+
Established in:
1972

Drug Substance (CDMO/CRO)

Small Molecule APIs
Small molecule APIs form the backbone of many pharmaceutical drugs due to their low molecular weight and ease of synthesis. They are widely used in treating a range of diseases and are typically produced through chemical synthesis in GMP-compliant facilities.
Contact supplier

Replies quickly

Drug Product (CMO)

Oral solid products
Oral solid dosage forms like tablets and capsules are the most common drug delivery formats. CMOs offer services in formulation, tableting, encapsulation, and packaging under GMP conditions.
Contact supplier

Replies quickly

Tablets & Capsules
Tablets and capsules are the most widely used oral dosage forms due to their stability and patient compliance. CMOs provide formulation development, compression, encapsulation, and packaging services under GMP standards.
Contact supplier

Replies quickly

Contact Olpha for Contract Services Expertise

Connect with Olpha, a leading pharmaceutical company from Latvia. They offer specialized Drug Substance (CDMO/CRO), Drug Product (CMO), of which the services for CMO/CDMO include Tablets & Capsules. Contact Olpha for free and discover if they are the perfect partner for your pharmaceutical needs.

Drug Substance (CDMO/CRO)

Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.


Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.


Key Functions of Drug Substance CDMOs/CROs:


  • API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.

  • Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.

  • GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.

  • Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.

  • Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.


Explore Leading API CDMOs and CROs

Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.

Drug Product (CMO)

Drug Product CMOs focus on the manufacturing and packaging of finished pharmaceutical dosage forms. These contract partners provide scalable production solutions that meet global regulatory and quality standards, supporting pharma companies throughout the drug product lifecycle.


Pharmaoffer’s Drug Product CMO category includes providers capable of manufacturing oral solids, injectables, topical formulations, and more—whether for clinical trials or commercial distribution.


Key Functions of Drug Product CMOs:


  • Formulation Development: Supporting the transition from drug substance to drug product through formulation optimization and compatibility testing.

  • Clinical and Commercial Manufacturing: Offering pilot-scale to high-volume manufacturing for various dosage forms under GMP conditions.

  • Packaging and Serialization: Providing primary and secondary packaging with serialization and tamper-proof labeling to meet compliance requirements.

  • Regulatory Support: Ensuring that all production meets FDA, EMA, and ICH standards for drug product quality, safety, and traceability.

  • Flexible Production Lines: Handling diverse dosage forms including tablets, softgels, liquids, and sterile injectables.


Partner with Proven Drug Product CMOs

Through Pharmaoffer, discover CMOs that excel in drug product manufacturing. Whether you need small-scale batches or full commercial output, our platform connects you with the right partners for compliant, cost-effective solutions.

Oral solid products

Oral solid products include tablets and capsules. CMOs provide formulation development, manufacturing, and packaging of solid dosage forms.

Tablets & Capsules

Tablets and capsules are common oral solid forms. CMOs offer formulation, compression, encapsulation, and GMP-compliant manufacturing services.

Olpha


Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines and chemical pharmaceutical products

Olpha Group includes a network of medical and pharmaceutical enterprises specialising in their own discipline, covering a wide range of areas.

Key areas
The key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. Olainfarm has a long-standing technological and know-how advantage in adamantane, quinuclidine and nitrofurane chemistry.

Certifications
Olpha is certified in accordance with the requirements of the EU GMP for APIs and FDFs, the U.S. cGMP for certain APIs (FDA), TGA for FDFs (Australia), CEP for certain APIs, ISO 14001 Environmental Management System and ISO 17025 Laboratory Management System.